140 related articles for article (PubMed ID: 9373785)
1. Use of [3H]-clozapine as a ligand of the dopamine D4 receptor subtype in peripheral tissues.
Ricci A; Bronzetti E; Rossodivita I; Amenta F
J Auton Pharmacol; 1997 Aug; 17(4):261-7. PubMed ID: 9373785
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study.
Ricci A; Bronzetti E; Felici L; Tayebati SK; Amenta F
Neurosci Lett; 1997 Jun; 229(2):130-4. PubMed ID: 9223608
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart.
Ricci A; Bronzetti E; Fedele F; Ferrante F; Zaccheo D; Amenta F
J Auton Pharmacol; 1998 Apr; 18(2):115-21. PubMed ID: 9730266
[TBL] [Abstract][Full Text] [Related]
4. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
Seeman P; Corbett R; Van Tol HH
Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]clozapine binding sites in rat brain.
Kusumi I; Matsubara S; Takahashi Y; Ishikane T; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):51-64. PubMed ID: 8695057
[TBL] [Abstract][Full Text] [Related]
6. [3H]Clozapine is not a suitable radioligand for the labelling of D4 dopamine receptors in postmortem human brain.
Flamez A; de Backer JP; Wilczak N; Vauquelin G; de Keyser J
Neurosci Lett; 1994 Jul; 175(1-2):17-20. PubMed ID: 7970202
[TBL] [Abstract][Full Text] [Related]
7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
8. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
[TBL] [Abstract][Full Text] [Related]
9. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland.
Amenta F; Ricci A
Clin Exp Hypertens; 1995 May; 17(4):669-88. PubMed ID: 7795580
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
13. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
[TBL] [Abstract][Full Text] [Related]
14. Clozapine occupies high levels of dopamine D2 receptors.
Seeman P; Kapur S
Life Sci; 1997; 60(12):PL 207-16. PubMed ID: 9061054
[TBL] [Abstract][Full Text] [Related]
15. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
Assié MB; Sleight AJ; Koek W
Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973
[TBL] [Abstract][Full Text] [Related]
16. Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study.
Ricci A; Bronzetti E; Felici L; Greco S; Amenta F
J Neuroimmunol; 1998 Dec; 92(1-2):191-5. PubMed ID: 9916894
[TBL] [Abstract][Full Text] [Related]
17. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.
Haubmann C; Hübner H; Gmeiner P
Bioorg Med Chem Lett; 1999 Jul; 9(14):1969-72. PubMed ID: 10450964
[TBL] [Abstract][Full Text] [Related]
18. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.
Heuillet E; Petitet F; Mignani S; Malleron JL; Lavayre J; Néliat G; Doble A; Blanchard JC
Eur J Pharmacol; 1996 Oct; 314(1-2):229-33. PubMed ID: 8957240
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
Seeman P; Corbett R; Nam D; Van Tol HH
Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
